Product name:Dapagliflozin
CAS: 461432-26-8
Molecular Formula: C21H25ClO6
Molecular Weight: 408.875
Product description:Through the inhibition of sodium - glucose transporters (SGLT2) - 2 kidney in a make glucose is absorbed into the bloodstream protein, and play a role. It has also made redundant glucose be excreted out through urine, thus under the condition of without any increase in insulin secretion to improve glycemic control. Use this drug for patients with normal renal function, according to severe renal insufficiency in patients. This product alone or in combination with metformin, pioglitazone, Glenn urea, insulin and other drugs used in combination, can be significantly reduced in patients with type 2 diabetes HbA1c and fasting glucose, incidence of adverse reactions similar to placebo, low risk of hypoglycemia, can reduce weight.